Limitless Potential.
Precision Design.
Enduring Impact.
Aiming to transform the treatment of autoimmune diseases and cancer by developing allogeneic, iPSC-derived cell therapies.
PRESS RELEASES + EVENTS
view all
August 22, 2025
Century Therapeutics to Present at H.C. Wainwright 27th Annual Global Investment Conference
PHILADELPHIA, Aug. 22, 2025 (GLOBE NEWSWIRE) — Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), an innovative…
August 14, 2025
Century Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update
Patient dosing ongoing in CALiPSO-1 trial; on track to report clinical data for CNTY-101 in…
About us
We are building an industry-leading, allogeneic, iPSC-derived cell therapy platform for autoimmune diseases and cancer.
OUR SCIENCE
We are leveraging the unlimited self-renewing capacity of induced pluripotent stem cells (iPSC) and cutting-edge cellular engineering and manufacturing technologies to develop fit-for-purpose products with functionalities designed to overcome the limitations of existing cell therapies.
